jueves, 25 de septiembre de 2025
What's New Today +++
Innovative Designs for Clinical Trials of Cellular and Gene Therapy Products in Small Populations
Draft Guidance for Industry
September 2025
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/innovative-designs-clinical-trials-cellular-and-gene-therapy-products-small-populations?utm_medium=email&utm_source=govdelivery
Postapproval Methods to Capture Safety and Efficacy Data for Cell and Gene Therapy Products
Draft Guidance for Industry
September 2025
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/postapproval-methods-capture-safety-and-efficacy-data-cell-and-gene-therapy-products?utm_medium=email&utm_source=govdelivery
Expedited Programs for Regenerative Medicine Therapies for Serious Conditions
Draft Guidance for Industry
September 2025
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/expedited-programs-regenerative-medicine-therapies-serious-conditions-0?utm_medium=email&utm_source=govdelivery
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario